Technical Analysis for AVCO - Avalon GloboCare Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
2.54 | -1.93% | -0.05 |
AVCO closed down 1.93 percent on Wednesday, September 18, 2019, on 1.44 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| See historical AVCO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Uptrend | Bullish | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | -1.93% | |
| Wide Bands | Range Expansion | -1.93% | |
| Above Upper BB | Strength | -1.93% | |
| Overbought Stochastic | Strength | -1.93% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/03/2019
- Sector: Healthcare
- Industry: Medical Care
Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.
Medicine Diseases Disease Infectious Diseases Oncology Immunotherapy Regenerative Medicine Infectious Disease Exosome Fibrotic Diseases Vesicles
Medicine Diseases Disease Infectious Diseases Oncology Immunotherapy Regenerative Medicine Infectious Disease Exosome Fibrotic Diseases Vesicles
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more AVCO news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 13.5 |
| 52 Week Low | 1.665 |
| Average Volume | 115,454 |
| 200-Day Moving Average | 3.1641 |
| 50-Day Moving Average | 2.0441 |
| 20-Day Moving Average | 2.0743 |
| 10-Day Moving Average | 2.2785 |
| Average True Range | 0.1589 |
| ADX | 27.29 |
| +DI | 34.1213 |
| -DI | 8.3101 |
| Chandelier Exit (Long, 3 ATRs ) | 2.1733 |
| Chandelier Exit (Short, 3 ATRs ) | 2.1417 |
| Upper Bollinger Band | 2.5978 |
| Lower Bollinger Band | 1.5508 |
| Percent B (%b) | 0.94 |
| BandWidth | 50.474859 |
| MACD Line | 0.1366 |
| MACD Signal Line | 0.0646 |
| MACD Histogram | 0.072 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.81 | ||||
| Resistance 3 (R3) | 2.81 | 2.73 | 2.77 | ||
| Resistance 2 (R2) | 2.73 | 2.66 | 2.73 | 2.75 | |
| Resistance 1 (R1) | 2.63 | 2.62 | 2.59 | 2.63 | 2.73 |
| Pivot Point | 2.55 | 2.55 | 2.53 | 2.55 | 2.55 |
| Support 1 (S1) | 2.45 | 2.48 | 2.41 | 2.45 | 2.35 |
| Support 2 (S2) | 2.37 | 2.44 | 2.37 | 2.33 | |
| Support 3 (S3) | 2.27 | 2.37 | 2.32 | ||
| Support 4 (S4) | 2.27 |
